Mastering Concepts in IBD & IBS: New Therapies, New Paradigms

Date & Location
Saturday, September 9, 2017 7:30 AM - 12:20 PM   St. Louis, St. Louis, MO

Family Medicine, Gastroenterology, Nurse Practitioner, Physician Assistants


The Chase Park Plaza
Lindell Ballroom
212 North Kingshighway Blvd.          
Saint Louis, Missouri  63108

At the conclusion of this activity, participants should be able to:
  1. Implement management strategies for irritable bowel syndrome
  2. How to incorporate non-medical and alternative therapies into treatment of IBS
  3. Analyze and evaluate advances in the management of irritable bowel syndrome
  4. Empower the gastroenterologist to maximize current therapy by identifying how to use and order drug level testing
  5. Educate regarding upcoming therapies in IBD and IBS
  6. Discuss special issues of IBD in the cancer patient, elderly population, and pregnant women. Are our medicines safe?
  7. Implement treatment strategies and goals for patients with chronic gastrointestinal pain


Saturday,September 9, 2017

Chase Park Plaza Hotel
212 N. Kingshighway
St. Louis, Mo 63108

Katie S. Schroeder, MD
Assistant Professor, Department of Internal Medicine
Division of Gastroenterology and Hepatology


In recent years, several advancements have led investigators to readdress the complex issues involved in the classification of inflammatory bowel diseases.  From the clinician's perspective, accurate classification of these diseases, assessment of disease prognosis, and, particularly, selection of the most appropriate therapy for each disease sub-type, driven by an attempt to understand the pathophysiology of the different manifestations of Crohn's disease, ulcerative colitis, and indeterminate colitis, would have potential benefits with respect to patient counseling. Overlap between the clinical and research based agendas has become even more apparent with identification of novel genetic determinants and serological markers which have proven useful with respect to subclassifying disease at the bedside, but may also allow new insights into disease pathogenesis and help clinicians in detecting patients at risk and improving patient management. For the routine gastroenterologist, there is a paucity of educational resources in IBD. This is a field that is extensively changing with every new medication and every new published manuscript. this makes it hard for the general gastroenterologist to manage IBD and provide standard of care for IBD patients. Most gastroenterologists rely on educational programs to get updated on the new therapies, and new paradigm in treatment.

For the clinical gastroenterologist, irritable bowel syndrome is one of the most commonly seen digestive problems. The understanding of irritable bowel syndrome (IBS) has undergone a rapid e4volution with scientific advancement. The care of this disease generates a significant health care burden. There are well-established diagnostic criteria and algorithms for the initial evaluation of patients presenting with the symptoms of IBS. The symptoms can be targeted for therapy with a variety of pharmaceutical and nonpharmaceutical agents.Therapy should be individualized for the patient, and the cornerstone for any effective treatment strategy should be the solid patient-physician relationship. however, the use of newer modalities to address multiple IBS symptoms will be an integral part of the treatment algorithm, especially as more scientific validation occurs. Pharmacotherapy directed at individual symptoms has been the standard of care up to now. It is important to establish realistic goals and expectations, with the patient understanding there is no "cure" for IBS, but rather use of tools to help with symptom control and overall QOL measurements.

Didactic sessions will be followed up by Question & Answer discussions.

Gastroenterology, Internal Medicine, Primary Care Physicians, Fellows, Residents, Nurse Practitioners, Physician Assistants, and registered nurse

Physicians (MDs & DOs) and Non-physicians (PAs & NPs) .......... $75.00
SLU Alumni ......... $35.00
SLU & SSMSLUH Faculty, Fellows, & Residents ........ Complimentary Registration (must register with SLU or SSMSLUH email address)

  • If AMA Continuing Medical Education credit is desired, please pay additional SLU and SSMSLUH credit tracking/certificate fee ...... $25.00

Until August 30, 2017 ...... Refund minus $15.00 cancellation fee

After August 30, 2017 ...... No Refund